Literature DB >> 21774673

Cancer screening practices among physicians in the national breast and cervical cancer early detection program.

Vicki B Benard1, Mona S Saraiya, Ashwini Soman, Katherine B Roland, K Robin Yabroff, Jackie Miller.   

Abstract

BACKGROUND: The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides low-income, uninsured women with screening and diagnostic services for breast and cervical cancer. Our study was conducted to describe the demographic and practice characteristics of participating and nonparticipating physicians, as well as their beliefs, adoption of new screening technologies, and recommendations for breast and cervical cancer screening.
METHODS: From a 2006-2007 nationally representative survey, we identified 1,111 practicing primary care physicians who provide breast and cervical cancer screenings and assessed their recommendations using clinical vignettes related to screening initiation, frequency, and cessation. Responses of physicians participating in the NBCCEDP were compared with those from nonparticipating physicians.
RESULTS: Of the physicians surveyed, 15% reported participation in the NBCCEDP, 65% were not participants, and 20% were not sure or did not respond to this question. Program physicians were significantly more likely to practice in multispecialty settings, in a rural location, and in a hospital or clinic setting and had more patients who were female and insured by Medicaid or uninsured compared with nonprogram physicians. Beliefs about the effectiveness of screening tools or procedures in reducing breast or cervical cancer mortality were similar by program participation. Adoption of new technologies, including digital mammography and human papillomavirus (HPV) testing, and making guideline-consistent recommendations for screening initiation, frequency, and cessation did not differ significantly by program participation.
CONCLUSIONS: Although there may be differences in physician characteristics and practice settings, the beliefs and screening practices for both breast and cervical cancer are similar between program and nonprogram providers.

Entities:  

Mesh:

Year:  2011        PMID: 21774673      PMCID: PMC3233212          DOI: 10.1089/jwh.2010.2530

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  18 in total

Review 1.  American Cancer Society guideline for the early detection of cervical neoplasia and cancer.

Authors:  Debbie Saslow; Carolyn D Runowicz; Diane Solomon; Anna-Barbara Moscicki; Robert A Smith; Harmon J Eyre; Carmel Cohen
Journal:  CA Cancer J Clin       Date:  2002 Nov-Dec       Impact factor: 508.702

2.  Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.

Authors:  Steven S Coughlin; Trevor D Thompson; H Irene Hall; Pamela Logan; Robert J Uhler
Journal:  Cancer       Date:  2002-06-01       Impact factor: 6.860

3.  American Cancer Society guidelines for breast cancer screening: update 2003.

Authors:  Robert A Smith; Debbie Saslow; Kimberly Andrews Sawyer; Wylie Burke; Mary E Costanza; W Phil Evans; Roger S Foster; Edward Hendrick; Harmon J Eyre; Steven Sener
Journal:  CA Cancer J Clin       Date:  2003 May-Jun       Impact factor: 508.702

Review 4.  Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States.

Authors:  Christopher I Li
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

Review 5.  Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment?

Authors:  K Robin Yabroff; William F Lawrence; Jason C King; Patricia Mangan; Kathleen Shakira Washington; Bin Yi; Jon F Kerner; Jeanne S Mandelblatt
Journal:  J Rural Health       Date:  2005       Impact factor: 4.333

Review 6.  Human papillomavirus testing in primary cervical screening and abnormal Papanicolaou management.

Authors:  J Thomas Cox
Journal:  Obstet Gynecol Surv       Date:  2006-06       Impact factor: 2.347

7.  Common abnormal results of pap and human papillomavirus cotesting: what physicians are recommending for management.

Authors:  Zahava Berkowitz; Mona Saraiya; Vicki Benard; K Robin Yabroff
Journal:  Obstet Gynecol       Date:  2010-12       Impact factor: 7.661

8.  American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.

Authors:  Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell
Journal:  CA Cancer J Clin       Date:  2007 Mar-Apr       Impact factor: 508.702

9.  ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 42, April 2003. Breast cancer screening.

Authors: 
Journal:  Obstet Gynecol       Date:  2003-04       Impact factor: 7.661

10.  Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.

Authors:  Crystale Purvis Cooper; Mona Saraiya; Teresa Abend McLean; Judy Hannan; Jaime M Liesmann; Shyanika Wijesinha Rose; Herschel W Lawson
Journal:  J Womens Health (Larchmt)       Date:  2005-10       Impact factor: 2.681

View more
  11 in total

1.  Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.

Authors:  Nikki A Hawkins; Vicki B Benard; April Greek; Katherine B Roland; Diane Manninen; Mona Saraiya
Journal:  Prev Med       Date:  2013-09-05       Impact factor: 4.018

2.  Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines.

Authors:  Jennifer Tsui; Annika M Hofstetter; Karen Soren
Journal:  Prev Med       Date:  2014-03-17       Impact factor: 4.018

3.  Cervical cancer screening in the United States and the Netherlands: a tale of two countries.

Authors:  Dik Habbema; Inge M C M De Kok; Martin L Brown
Journal:  Milbank Q       Date:  2012-03       Impact factor: 4.911

4.  Preventing premature deaths from breast and cervical cancer among underserved women in the United States: insights gained from a national cancer screening program.

Authors:  Mary C White; Faye L Wong
Journal:  Cancer Causes Control       Date:  2015-03-18       Impact factor: 2.506

5.  Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers.

Authors:  K B Roland; V B Benard; A Greek; N A Hawkins; D Manninen; M Saraiya
Journal:  Prev Med       Date:  2013-04-28       Impact factor: 4.018

6.  Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.

Authors:  Katherine B Roland; Vicki B Benard; April Greek; Nikki A Hawkins; Mona Saraiya
Journal:  Vaccine       Date:  2014-08-12       Impact factor: 3.641

7.  When Guidelines Conflict: A Case Study of Mammography Screening Initiation in the 1990s.

Authors:  Mireille Jacobson; Srikanth Kadiyala
Journal:  Womens Health Issues       Date:  2017-09-19

8.  Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.

Authors:  Meg Watson; Vicki Benard; Lavinia Lin; Tanner Rockwell; Janet Royalty
Journal:  Cancer Causes Control       Date:  2015-03-21       Impact factor: 2.506

9.  Current cervical cancer screening knowledge, awareness, and practices among U.S. affiliated pacific island providers: opportunities and challenges.

Authors:  Julie S Townsend; Analía Romina Stormo; Katherine B Roland; Lee Buenconsejo-Lum; Susan White; Mona Saraiya
Journal:  Oncologist       Date:  2014-03-25

10.  Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009.

Authors:  Young Hwa Lee; Kui Son Choi; Hoo-Yeon Lee; Jae Kwan Jun
Journal:  J Gynecol Oncol       Date:  2012-01-09       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.